New award for teriparatide injections with amphastar. Ordering period is september 29, 2026 - september 28, 2027 with four one-year options
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0039
- Awardee
-
Amphastar Pharmaceuticals, Inc. UEI UHZLZ12LMJ31
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Teriparatide Injection (VA-26-00049896) Pre-Solicitation · 36E79726R0020 · Posted Apr 20, 2026
- Last date to order 5% complete
- IDV ceiling
- $53,872,440.00
- Award type
- Single award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The VA National Acquisition Center awarded a single-award indefinite-delivery contract to Amphastar Pharmaceuticals, Inc. on September 29, 2026, for the supply of Teriparatide Injection with a ceiling value of $53,872,440. No set-aside was used.
The contract supplies teriparatide 250 micrograms per milliliter in 2.24 milliliter pen format to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. Distribution occurs through the VA's and DOD's respective Pharmaceutical Prime Vendor Programs. The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing); the PSC is 6505 (Drugs and Biologicals).
The ordering period runs from September 29, 2026, through September 28, 2027, with four one-year options exercisable thereafter. The ultimate completion date is September 28, 2027.
The contract incorporates DEI Clause 52.222-90. Offerors were required to demonstrate an uninterrupted source of supply and submit the exact drug name as labeled along with the unique NDC number. The estimated annual requirement was 39,038 pens.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0039?
36E79726D0039 was awarded to Amphastar Pharmaceuticals, Inc. by National Acquisition Center (Headquarters) on September 29, 2026.
How much is contract 36E79726D0039 worth?
36E79726D0039's own ceiling is $53,872,440.
Who can order from contract 36E79726D0039?
36E79726D0039 is a single award indefinite delivery contract.
Was contract 36E79726D0039 competed?
The extent of competition for 36E79726D0039 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV